Thursday, January 25, 2018

Oncogene - Table of Contents alert Volume 37 Issue 4

If you are unable to see the message below, click here to view.

Are you new to ChIP? Diagenode can help. 

Diagenode provides complete ChIP-qPCR and ChIP-seq solutions making epigenetics research accessible. Eliminate the challenges of your epigenetics workflow with validated antibodies, kits, Bioruptor chromatin shearing systems, and our unique ChIPmentation and ChIP-seq automation system. Check out our new website that take you through a step-by-step guide of what you need for ChIP. 

Learn more

Volume 37, Issue 4 (January 2018)

In this issue
Original Articles
Short Communication
Also new
GEP-NET: COMPETE phase III clinical trial is open for recruitment

COMPETE evaluates the efficacy and safety of Targeted Radionuclide Therapy with n.c.a. 177Lu-Edotreotide (Solucin®) in patients with neuroendocrine tumors of gastroenteric or pancreatic origin (GEP-NET). For further information about inclusion, exclusion criteria and more, please visit our website
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed

Original Articles

A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression

C Chang, J Liu, W He, M Qu, X Huang et al.

Oncogene 2017 37 :415 - 426; October 02, 2017; 10.1038/onc.2017.332


Abstract | Full Text

AKT overactivation can suppress DNA repair via p70S6 kinase-dependent downregulation of MRE11

D Piscitello, D Varshney, S Lilla, M G Vizioli, C Reid et al.

Oncogene 2017 37 :427 - 438; October 02, 2017; 10.1038/onc.2017.340


Abstract | Full Text

Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy

V Mett, E A Komarova, K Greene, I Bespalov, C Brackett et al.

Oncogene 2017 37 :439 - 449; October 02, 2017; 10.1038/onc.2017.346


Abstract | Full Text

The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia

J Serio, J Ropa, W Chen, M Mysliwski, N Saha et al.

Oncogene 2017 37 :450 - 460; September 25, 2017; 10.1038/onc.2017.337


Abstract | Full Text

EZH2 promotes neoplastic transformation through VAV interaction-dependent extranuclear mechanisms

N Venkatesan, J F Wong, K P Tan, H H Chung, Y H Yau et al.

Oncogene 2017 37 :461 - 477; October 02, 2017; 10.1038/onc.2017.309


Abstract | Full Text

TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1–TSC2 complex

P Guo, X Ma, W Zhao, W Huai, T Li et al.

Oncogene 2017 37 :478 - 488; October 02, 2017; 10.1038/onc.2017.349


Abstract | Full Text

A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation

Y Chhabra, H Y Wong, L F Nikolajsen, H Steinocher, A Papadopulos et al.

Oncogene 2017 37 :489 - 501; October 02, 2017; 10.1038/onc.2017.352


Abstract | Full Text

Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration

X Zheng, J Chi, J Zhi, H Zhang, D Yue et al.

Oncogene 2017 37 :502 - 511; October 02, 2017; 10.1038/onc.2017.354


Abstract | Full Text

Super-enhancers define a proliferative PGC-1α-expressing melanoma subgroup sensitive to BET inhibition

K A Gelato, L Schöckel, O Klingbeil, T Rückert, R Lesche et al.

Oncogene 2017 37 :512 - 521; October 09, 2017; 10.1038/onc.2017.325


Abstract | Full Text

Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance

A Visvanathan, V Patil, A Arora, A S Hegde, A Arivazhagan et al.

Oncogene 2017 37 :522 - 533; October 09, 2017; 10.1038/onc.2017.351


Abstract | Full Text

LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation

Y He, Y Zhao, L Wang, L R Bohrer, Y Pan et al.

Oncogene 2017 37 :534 - 543; October 09, 2017; 10.1038/onc.2017.353


Abstract | Full Text

Short Communication

Loss of protein phosphatase 2A regulatory subunit B56δ promotes spontaneous tumorigenesis in vivo

C Lambrecht, L Libbrecht, X Sagaert, P Pauwels, Y Hoorne et al.

Oncogene 2017 37 :544 - 552; October 02, 2017; 10.1038/onc.2017.350


Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: